Occutrack
Singapore, Singapore
Degeneration of the macula in the eye occurs with age and results in blurred or distorted vision, often with a dark spot blocking the centre of the visual field. Unfortunately, the progression of the disease is unpredictable and clinical planning is often difficult, leading to irreversible progression of the disease. Occutrack’s patented Crystalsight AI detects the user’s gaze points on the screen and generates a new pattern elsewhere on the screen. All the user has to do is look at the screen! Our system uses gaze tracking and advanced eye-tracking algorithms to provide a comprehensive and intelligent assessment of a person’s visual performance. By tracking these optokinetic movements with displayed patterns on the screen, eye health can be determined. Automated Vision Assessment and Impairment Detection through Gaze Analysis (“AVIGA”).
Company Info
- Founded
- 2019
- Website
- occutrack.com.sg/
Only accessible to MedStartr community members.
Join nowWhat do you think of Occutrack?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.